Life science companies will need an integrated digital data strategy with internal and external processes to stay successful and to make use of the available data. At the center of the new life sciency ecosystem is the patient centric view.
Every generation believes its problems are bigger, more complex and more unsolvable than those of the previous generation. And when it comes to our generation, this does hold true in some respects. The realization that a radical transformation is needed in many places has never been as widespread as it is today.
With private equity activities reaching a record high and mounting pressure to innovate and transform, the 2017 M&A year in Switzerland was a lively one. Remarkable transactions could be seen in the consumer goods, technology & media and pharmaceutical industries, in particular. Get insight into the biggest deals, industry convergence and outlook for 2018.